Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice

Diabetes: a driver for heart failure

(2011) A. A. Voors et al.   HEART

Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow

(2011) C. Andrew Boswell et al.   PLoS One

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice

(2010) Mitomu Kioi et al.   JOURNAL OF CLINICAL INVESTIGATION

Membrane receptors: Structure and function of the relaxin family peptide receptors

(2010) Roy C.K. Kong et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Activation of adenosine A2A receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice

(2010) Domenica Altavilla et al.   SURGERY

Scar Prevention and Cosmetically Enhanced Wound Healing Using Relaxin

(2009) Dennis R. Stewart   Annals of the New York Academy of Sciences

Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study

(2009) John R Teerlink et al.   LANCET

Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player

(2008) Dietmar Vestweber et al.   TRENDS IN CELL BIOLOGY

Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse

(2008) Mariarosaria Galeano et al.   WOUND REPAIR AND REGENERATION